Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fiverr International Ltd (FVRR) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance

Fiverr International LtdTrade
IDEXX Laboratories, Inc.Trade

Price performance (Past 24H)

Key statistics

Fiverr International Ltd vs IDEXX Laboratories, Inc. — how do they compare? Fiverr International Ltd trades at $11.64 (market cap $404.45M), while IDEXX Laboratories, Inc. trades at $573.7 (market cap $43.94B). The key difference: IDEXX Laboratories, Inc. is far larger — about 108.6× Fiverr International Ltd's market cap, and IDEXX Laboratories, Inc. is trading nearer its 52-week high, Fiverr International Ltd nearer its low. Which is the better fit depends on your goals.

FVRRIDXX
Market Cap
$404.45M$43.94B
Sector
IndustrialsHealth
52-Week High
$26.67$766.68
52-Week Low
$9.62$514.61
Enterprise Value
$135.05M$44.84B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fiverr International Ltd

Fiverr International (FVRR) trades at $11.82, up 6.78% in the last session, showing strong momentum despite recent volatility. The stock exhibits bullish technical signals with moving averages supporting upward movement. Fundamentally, revenue grew to $430.91M in 2025 with improving net margins, while valuation ratios like P/E of 14.61 and P/S of 0.97 suggest potential undervaluation. Recent news highlights Fiverr's upcoming Q2 2026 earnings report on July 29, 2026, amid mixed sentiment from financial media.

The outlook for FVRR hinges on execution of its strategic shift and Q2 earnings performance. Opportunities include attractive valuation multiples and operational cash flow growth, but risks involve declining active buyers and ongoing legal investigations. Analyst consensus leans neutral with 41% buy ratings, reflecting cautious optimism pending clearer business traction.

IDEXX Laboratories, Inc.

IDXX trades at $572.38, up 5.86% over 24 hours, with a neutral technical signal and strong fundamentals. The company reported Q1 2026 EPS of $3.47, beating estimates, and maintains robust profitability with a 24.63% net margin. Revenue growth accelerated to $4.3 billion in 2025, supported by innovation in veterinary diagnostics and AI integration. Cash flow from operations remains healthy at $1.18 billion, though net cash flow was negative $108 million due to financing activities.

Outlook is positive given consistent earnings beats and analyst consensus leaning buy (59% of ratings). Key risks include high valuation multiples (P/E 40.99) and competitive pressures in medical devices. The stock's proximity to its 52-week high suggests momentum but warrants caution on pullbacks. Institutional sentiment is bolstered by product expansions like taeniid tapeworm detection and SDMA integration for kidney disease screening.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Fiverr International Ltd

Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.

Read more on FVRR

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

Read more on IDXX